Depression after status epilepticus: Behavioural and biochemical deficits and effects of fluoxetine

Brain

Volumn 131, Issue 8, 2008, Pages 2071-2083

  Mazarati, Andréy ^a   Siddarth, Prabha ^a   Baldwin, Roger A ^a   Shin, Don ^a   Caplan, Rochelle ^a   Sankar, Raman ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Comorbidity; Depression; Epilepsy; Hippocampus; Serotonin

Indexed keywords

FLUOXETINE; LITHIUM CHLORIDE; PILOCARPINE; SACCHARIN; SEROTONIN;

ANHEDONIA; ARTICLE; BEHAVIOR; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; EPILEPTIC STATE; FORCED SWIMMING TEST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TASTE DISORDER;

EID: 49449113629     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awn117     Document Type: Article

References (73)

1. Adamec R, Blundell J, Burton P. Anxiolytic effects of kindling role of anatomical location of the kindling electrode in response to kindling of the right basolateral amygdala. Brain Res 2004; 1024: 44-58.
2. Adell A, Casanovas JM, Artigas F. Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas. Neuropharmacology 1997; 36: 735-41.
3. Albano C, Cupello A, Mainardi P, Scarrone S, Favale E. Successful treatment of epilepsy with serotonin reuptake inhibitors: proposed mechanism. Neurochem Res 2006; 31: 509-14.
4. Azmitia EC, Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. Br J Pharmacol 1978; 121: 1180-6.
5. Bianchi M, Heidbreder C, Crespi F. Cytoskeletal changes in the hippocampus following restraint stress: role of serotonin and microtubules. Synapse 2003; 49: 188-94.
6. Briellmann RS, Hopwood MJ, Jackson GD. Major depression in temporal lobe epilepsy with hippocampal sclerosis: clinical and imaging correlates. J Neurol Neurosurg Psychiatry 2007; 78: 1226-30.
7. Broderick PA, Pacia SV, Doyle WK, Devinsky O. Monoamine neurotransmitters in resected hippocampal subparcellations from neocortical and mesial temporal lobe epilepsy patients: in situ microvoltammetric studies. Brain Res 2000; 878: 48-63.
8. Cascino GD, Jack CR Jr, Parisi JE, Sharbrough FW, Hirschorn KA, Meyer FB, et al. Magnetic resonance imaging-based volume studies in temporal lobe epilepsy: pathological correlations. Ann Neurol 1991; 30: 31-6.
9. Cavalheiro EA, Fernandes MJ, Turski L, Naffah-Mazzacoratti MG. Spontaneous recurrent seizures in rats: amino acid and monoamine determination in the hippocampus. Epilepsia 1994; 35: 1-11.
10. Cavalheiro EA, Naffah-Mazzacoratti MG, Mello LE, Leite JA. The pilocarpine model of seizures. In: Pitkanen A, Schwartzkroin PA, Moshe SL, editors. Models of seizures and epilepsy. Amsterdam et al.: Elsevier; 2006. p. 433-48.
11. Cheetham SC, Crompton MR, Czudek C, Horton RW, Katona CL, Reynolds GP. Serotonin concentrations and turnover in brains of depressed suicides. Brain Res 1989; 502: 332-40.
12. Chuma T, Taguchi K, Kato M, Abe K, Utsunomiya I, Miyamoto K, et al. Modulation of noradrenergic and serotonergic transmission by noxious stimuli and intrathecal morphine differs in the dorsal raphe nucleus of anesthetized rat: in vivo voltammetric studies. Neurosci Res 2002; 44: 37-44.
13. Clark M, Weiss SR, Post RM. Autoradiographic analysis of serotonin receptors and transporter in kindled rat brain. Neurosci Lett 1993; 161: 21-6.
14. El Yacoubi M, Bouali S, Popa D, Naudon L, Leroux-Nicollet I, Hamon M, et al. Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression. Proc Natl Acad Sci USA 2003; 100: 6227-32.
15. Frankfurt M, McKittrick CR, Luine VN. Short-term fluoxetine treatment alters monoamine levels and turnover in discrete brain nuclei. Brain Res 1994; 650: 127-32.
16. Gilliam FG, Maton BM, Martin RC, Sawrie SM, Faught RE, Hugg JW, et al. Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy. Neurology 2007; 68: 364-8.
17. Gronli J, Fiske E, Murison R, Bjorvatn B, Sorensen E, Ursin R, et al. Extracellular levels of serotonin and GABA in the hippocampus after chronic mild stress in rats. A microdialysis study in an animal model of depression. Behav Brain Res 2007; 181: 42-51.
18. Groticke I, Hoffmann K, Loscher W. Behavioral alterations in the pilocarpine model of temporal lobe epilepsy in mice. Exp Neurol 2007; 207: 329-49.
19. Harden CL. The co-morbidity of depression and epilepsy: epidemiology, etiology, and treatment. Neurology 2002; 59 (Suppl 4): 48-55.
20. Hernandez EJ, Williams PA, Dudek FE. Effects of fluoxetine and TFMPP on spontaneous seizures in rats with pilocarpine-induced epilepsy. Epilepsia 2002; 43: 1337-45.
21. Iravani MM, Kruk ZL. Real-time measurement of stimulated 5-hydroxytryptamine release in rat substantia nigra pars reticulata brain slices. Synapse 1997; 25: 93-102.
22. Jackson BP, Dietz SM, Wightman RM. Fast-scan cyclic voltammetry of 5-hydroxytryptamine. Anal Chem 1995; 67: 1115-20.
23. Jahng JW, Kim JG, Kim HJ, Kim BT, Kang DW, Lee JH. Chronic food restriction in young rats results in depression- and anxiety-like behaviors with decreased expression of serotonin reuptake transporter. Brain Res 2007; 1150: 100-7.
24. Jobe PC. Common pathogenic mechanisms between depression and epilepsy: an experimental perspective. Epilepsy Behav 2003; 4: S14-S24.
25. Jobe PC, Dailey JW, Wernicke JF. A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. Crit Rev Neirobiol 1999; 13: 317-56.
26. Jones NC, Salzberg MR, Kumar G, Couper A, Morris MJ, O'Brien TJ. Elevated anxiety and depressive-like behavior in a rat model of genetic generalized epilepsy suggesting common causation. Exp Neurol 2008; 209: 254-60.
27. Kampov-Polevoy AB, Rezvani AH. Fluoxetine reduces saccharin-induced elevation of fluid intake in alcohol-preferring Fawn-Hooded rats. Pharmacol Biochem Behav 1997; 58: 51-4.
28. Kanner AM. Depression in epilepsy: a neurobiologic perspective. Epilepsy Curr 2005; 5: 21-7.
29. Kanner AM, Balabanov A. Depression and epilepsy: how closely related are they? Neurology 2002; 58: S27-39.
30. Kennett GA, Joseph MH. Does in vivo voltammetry in the hippocampus measure 5-HT release? Brain Res 1982; 236: 305-16.
31. Kirby LG, Chou-Green JM, Davis K, Lucki I. The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res 1997; 760: 218-30.
32. Koh S, Magid R, Chung H, Stine CD, Wilson DN. Depressive behavior and selective down-regulation of serotonin receptor expression after early-life seizures: reversal by environmental enrichment. Epilepsy Behav 2007; 10: 26-31.
33. Kondziella D, Alvestad S, Vaaler A, Sonnewald U. Which clinical and experimental data link temporal lobe epilepsy with depression? J Neurochem 2007; 103: 2136-52.
34. Leander JD. Fluoxetine suppresses palatability-induced ingestion. Psychopharmacology 1987; 91: 285-7.
35. Lee JH, Kim HJ, Kim JG, Ryu V, Kim BT, Kang DW, et al. Depressive behaviors and decreased expression of serotonin reuptake transporter in rats that experienced neonatal maternal separation. Neurosci Res 2007; 58: 32-9.
36. Louw D, Sutherland GR, Glavin GB, Girvin J. A study of monoamine metabolism in human epilepsy. Can J Neurol Sci 1989; 16: 394-7.
37. Ma J, Leung LS. Schizophrenia-like behavioral changes after partial hippocampal kindling. Brain Res 2004; 997: 111-8.
38. Mann JJ, Arango V, Marzuk PM, Theccanat S, Reis DJ. Evidence for the 5-HT hypothesis of suicide. A review of post-mortem studies. Br J Psychiatry 1989; 8 (Suppl): 7-14.
39. Manna I, Labate A, Gambardella A, Forabosco P, La Russa A, Le Piane E, et al. Serotonin transporter gene (5-Htt): association analysis with temporal lobe epilepsy. Neurosci Lett 2007; 421: 52-6.
40. Mazarati A, Shin D, Auvin S, Caplan R, Sankar R. Kindling epileptogenesis in immature rats leads to persistent depressive behavior. Epilepsy Behav 2007; 10: 377-83.
41. Mazarati AM, Baldwin RA, Shinmei S, Sankar R. In vivo interaction between serotonin and galanin receptors types 1 and 2 in the dorsal raphe: implication for limbic seizures. J Neurochem 2005; 95: 1495-503.
42. Moreau JL. Validation of an animal model of anhedonia, a major symptom of depression. Encephale 1997; 23: 280-9.
43. Mortazavi F, Ericson M, Story D, Hulce VD, Dunbar GL. Spatial learning deficits and emotional impairments in pentylenetetrazole-kindled rats. Epilepsy Behav 2005; 7: 629-38.
44. Muscat R, Papp M, Willner P. Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline. Psychopharmacology 1992; 109: 433-8.
45. Nestler EJ, Carlezon WA Jr. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006; 59: 1151-9.
46. Overstreet DH, Friedman E, Mathe AA, Yadid G. The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev 2005; 29: 739-59.
47. Overstreet DH, Pucilowski O, Rezvani AH, Janowsky DS. Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. Psychopharmacology 1995; 121: 27-37.
48. Overstreet DH, Rezvani AH, Djouma E, Parsian A, Lawrence AJ. Depressive-like behavior and high alcohol drinking co-occur in the FH/WJD rat but appear to be under independent genetic control. Neurosci Biobehav Rev 2007; 31: 103-14.
49. Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology 1999; 147: 162-7.
50. Paxinos G, Watson C. The Rat brain in stereotaxic coordinates. San Diego et al.: Academic Press; 1986.
51. Porsolt RD, Bertin A, Blavet N, Deniel M, Jalfre M. Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 1979; 57: 201-10.
52. Pucilowski O, Overstreet DH. Effect of chronic antidepressant treatment on responses to apomorphine in selectively bred rat strains. Brain Res Bull 1993; 32: 471-5.
53. Pucilowski O, Overstreet DH, Rezvani AH, Janowsky DS. Chronic mild stress-induced anhedonia: greater effect in a genetic rat model of depression. Physiol Behav 1993; 54: 1215-20.
54. Racine RJ. Modification of seizure activity by electrical stimulation: II. motor seizures. Electroencephalogr. Clin Neurophysiol 1972; 32: 281-94.
55. Richardson EJ, Griffith HR, Martin RC, Paige AL, Stewart CC, Jones J, et al. Structural and functional neuroimaging correlates of depression in temporal lobe epilepsy. Epilepsy Behav 2007; 10: 242-9.
56. Rocha L, Lorigados-Pedre L, Orozco-Suarez S, Morales-Chacon L, Alonso-Vanegas M, Garcia-Maeso I, et al. Autoradiography reveals selective changes in serotonin binding in neocortex of patients with temporal lobe epilepsy. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1208-18.
57. Sankar R, Shin D, Mazarati AM, Liu H, Katsumori H, Lezama R, et al. Epileptogenesis after status epilepticus reflects age- and model-dependent plasticity. Ann Neurol 2000; 48: 580-9.
58. Sarkisova KY, Midzianovskaia IS, Kulikov MA. Depressive-like behavioral alterations and c-fos expression in the dopaminergic brain regions in WAG/Rij rats with genetic absence epilepsy. Behav Brain Res 2003; 144: 211-26.
59. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996; 93: 3908-13.
60. Shumake J, Gonzalez-Lima F. Brain systems underlying susceptibility to helplessness and depression. Behav Cogn Neurosci Rev 2003; 2: 198-221.
61. Spencer SS, Berg AT, Vickrey BG, Sperling MR, Bazil CW, Shinnar S, et al. Initial outcomes in the multicenter study of Epilepsy surgery. Neurology 2003; 61: 1680-5.
62. Szyndler J, Rok P, Maciejak P, Walkowiak J, Czlonkowska AI, Sienkiewicz-Jarosz H, et al. Effects of pentylenetetrazol-induced kindling of seizures on rat emotional behavior and brain monoaminergic systems. Pharmacol Biochem Behav 2002a; 73: 851-61.
63. Szyndler J, Wierzba-Bobrowicz T, Maciejak P, Siemiatkowski M, Rok P, Lehner M, et al. Pentylenetetrazol-kindling of seizures selectively decreases (3H)-citalopram binding in the CA-3 area of rat hippocampus. Neurosci Lett 2002b; 335: 49-53.
64. Szyndler J, Wierzba-Bobrowicz T, Skorzewska A, Maciejak P, Walkowiak J, Lechowicz W, et al. Behavioral, biochemical and histological studies in a model of pilocarpine-induced spontaneous recurrent seizures. Pharmacol Biochem Behav 2005; 81: 15-23.
65. Theodore WH. Does serotonin play a role in Epilepsy? Epilepsy Curr 2003; 3: 173-7.
66. Thompson MR, Li KM, Clemens KJ, Gurtman CG, Hunt GE, Cornish JL, et al. Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats. Neuropsychopharmacology 2004; 29: 694-704.
67. Wada Y, Shiraishi J, Nakamura M, Hasegawa H. Prolonged but not acute fluoxetine administration produces its inhibitory effect on hippocampal seizures in rats. Psychopharmacology 1995; 118: 305-9.
68. Willner P. Validity, reliability and utility of chronic mild stress model of depression: a 10 year review and evaluation. Psychopharmacology 1997; 134: 129-39.
69. Wintink AJ, Young NA, Davis AC, Gregus A, Kalynchuk LE. Kindling-induced emotional behavior in male and female rats. Behav Neurosci 2003; 117: 632-40.
70. Wrench J, Wilson SJ, Bladin PF. Mood disturbance before and after seizure surgery: a comparison of temporal and extratemporal resections. Epilepsia 2004; 45: 534-43.
71. Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, et al. Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol Biochem Behav 2005; 82: 200-6.
72. Zangen A, Overstreet DH, Yadid G. High serotonin and 5- hydroxyindoleacetic acid levels in limbic brain regions in a rat model of depression: normalization by chronic antidepressant treatment. J Neurochem 1997; 69: 2477-83.
73. Zobel A, Wellmer J, Schulze-Rauschenbach S, Pfeiffer U, Schnell S, Elger C, et al. Impairment of inhibitory control of the hypothalamic pituitary adrenocortical system in epilepsy. Eur Arch Psychiatry Clin Neurosci 2004; 254: 303-11.